QIF-T0093
highPPG pulse waveform biometric identification (cardiac signature fingerprinting via wearable optical sensor)
Tier 3 — Demonstrated (Lab-proven)
Legacy status: DEMONSTRATED
Photoplethysmography (PPG) sensors in smartwatches and fitness trackers measure blood volume changes through green LED light reflected from the wrist. The PPG waveform shape is unique per individual — determined by cardiac output, arterial stiffness, vessel geometry, and autonomic tone. Biswas et al. (2019) demonstrated >98% identification accuracy using deep learning on PPG waveforms. Unlike heart rate (a single number), the full PPG waveform is a rich biometric containing: pulse amplitude, dicrotic notch depth, systolic/diastolic ratio, pulse transit time, and waveform morphology. This biometric is continuously captured by any wearable with a heart rate sensor (Apple Watch, Fitbit, Galaxy Watch, Oura Ring). The user consents to heart rate monitoring, not to biometric identification from their cardiac waveform. Combined with T0088 (gait) and T0079 (ear canal), the attacker has three independent biometric channels from consumer devices.
Technique Details
- Tactic
- QIF-S.FP
- Status
- DEMONSTRATED
- Bands
- S1, S2, S3
✚ Therapeutic Application
Wearable PPG sensor captures unique cardiac pulse waveform morphology determined by cardiovascular physiology; deep learning extracts biometric identity from waveform features
Clinical Analog
PPG-based cardiovascular health monitoring
Treats
- atrial fibrillation detection (Apple Watch FDA clearance)
- blood pressure estimation (pulse wave analysis)
- sleep apnea screening (SpO2 + pulse waveform)
- vascular stiffness assessment
Neural Impact
3 of 7 neural bands affected
Drag to rotate. Click a region to learn more.
Click or hover over a glowing region to see the attack techniques targeting it and their severity.
Scoring
NISS:1.1/BI:N/CR:N/CD:N/CV:I/RV:F/NP:N CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:H/SI:N/SA:N Governance
Neurorights at Risk
This technique threatens 2 of the 4 proposed neurorights (Ienca & Andorno, 2017).
FDORA §3305 Compliance
- ! CVSS partially captures risk; neural dimensions missing
- ! No FDA pathway for consumer sensor exploitation
Population Vulnerability
CRB vulnerability adjustment (γ=0.30) accounts for age, diagnosis severity, consent capacity, and device dependency.
| Population | NISS Base | Adjusted | Severity | Delta |
|---|---|---|---|---|
| Adult (Default) | 2.0 | 2.0 | Low | - |
| Child (10yr) + ADHD | 2.0 | 2.4 | Low | +0.35 |
| Adult with ALS | 2.0 | 2.3 | Low | +0.32 |
Validation Status
Theoretical / Not yet validated. This technique has not been independently tested. See the validation dashboard for what has been tested.